Journals / Turkish Journal of Medical Sciences / 2014 / Cilt: 44 - Sayı: 4

Endocrine abnormalities of patients with cleft lip and/or cleft palate during the neonatal period

Pages
696–702
Publication Date
2014-05-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Endocrinological evaluation of the patients with orofacial clefts in the neonatal period is a worthwhile endeavor to detect hormone deficiencies regardless of the type of the cleft.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:There are close interactions among the developing oral cavity, pituitary gland, and central nervous system (CNS) in early embryonic life.
📊
Key Findings & Data:Results: Endocrine abnormality was detected in 22 (70.9%) patients.
💡
Conclusion & Impact:Conclusion: Endocrinological evaluation of the patients with orofacial clefts in the neonatal period is a worthwhile endeavor to detect hormone deficiencies regardless of the type of the cleft.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Endocrine system diseases · cleft lip and palate · newborn

Abstract

There are close interactions among the developing oral cavity, pituitary gland, and central nervous system (CNS) in early embryonic life. In this study we aimed to screen endocrine abnormalities in patients with orofacial clefts in the neonatal period. Materials and methods: Thirty-one patients with isolated orofacial median clefts were included in the study. Pituitary, thyroid, and adrenal hormones were measured at the first week and remeasured in the third or fourth weeks. Imaging studies were done for detection of CNS anomalies in all patients. Results: Endocrine abnormality was detected in 22 (70.9%) patients. The number of patients with single and multiple endocrine abnormalities were 13 (41.9%) and 9 (29%), respectively. Thyroid hormone-related disorders were detected in 10 (32.3%) patients. Growth hormone deficiency was detected in 4 (12.9%) patients. Adrenocorticotrophic hormone and/or glucocorticoid deficiency was detected in 5 (16.1%) patients. Neonatal hypoglycemia due to endocrinological abnormalities was detected in 6 (19.4%) patients. Defected mini-puberty was seen in 2 (15.4%) patients. There was no relationship between the types of orofacial cleft and endocrine abnormalities. Conclusion: Endocrinological evaluation of the patients with orofacial clefts in the neonatal period is a worthwhile endeavor to detect hormone deficiencies regardless of the type of the cleft.

Özet

There are close interactions among the developing oral cavity, pituitary gland, and central nervous system (CNS) in early embryonic life. In this study we aimed to screen endocrine abnormalities in patients with orofacial clefts in the neonatal period. Materials and methods: Thirty-one patients with isolated orofacial median clefts were included in the study. Pituitary, thyroid, and adrenal hormones were measured at the first week and remeasured in the third or fourth weeks. Imaging studies were done for detection of CNS anomalies in all patients. Results: Endocrine abnormality was detected in 22 (70.9%) patients. The number of patients with single and multiple endocrine abnormalities were 13 (41.9%) and 9 (29%), respectively. Thyroid hormone-related disorders were detected in 10 (32.3%) patients. Growth hormone deficiency was detected in 4 (12.9%) patients. Adrenocorticotrophic hormone and/or glucocorticoid deficiency was detected in 5 (16.1%) patients. Neonatal hypoglycemia due to endocrinological abnormalities was detected in 6 (19.4%) patients. Defected mini-puberty was seen in 2 (15.4%) patients. There was no relationship between the types of orofacial cleft and endocrine abnormalities. Conclusion: Endocrinological evaluation of the patients with orofacial clefts in the neonatal period is a worthwhile endeavor to detect hormone deficiencies regardless of the type of the cleft.

🔖

Cite This Article

AKIN, M. A., KURTOĞLU, S., SARICI, D., AKIN, L., HATİPOĞLU, N. (2014). Endocrine abnormalities of patients with cleft lip and/or cleft palate during the neonatal period. Turkish Journal of Medical Sciences, Cilt: 44 - Sayı: 4, 696–702. https://ajindex.com/articles/228079

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cox TC. Taking it to the max: the genetic and developmental mechanisms coordinating midfacial morphogenesis and dysmorphology. Clin Genet 2004; 65: 163–176.
  2. Lowe LH, Booth TN, Joglar JM, Rollins NK. Midface anomalies in children. Radiographics 2000; 20: 907–922.
  3. Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC. Cleft lip and palate. Lancet 2009; 374: 1773–1785. Tuncbilek E. Türkiye’de konjenital malformasyon sikliği, dagilimi, risk faktörleri ve yenidoganlarin antropometrik degerlendirmesi. Ankara, Turkey: TÜBİTAK Matbaası; 1994 (in Turkish). Juriloff DM, Harris MJ. Mouse genetic models of cleft lip with or without cleft palate. Birth Defects Res A Clin Mol Teratol 2008; 82: 63–77.
  4. Osman M, Allan JC, Kramer B. A pharyngeal and ectopic hypophysis in a neonate with craniofacial abnormalities: a case report and review of development and structure. Cleft Palate Craniofac J 2006; 43: 117–122. Kjaer I. Human prenatal craniofacial development related to brain development under normal and pathologic conditions. Acta Odontol Scand 1995; 53: 135–143.
  5. Roitman A, Laron Z. Hypothalamo-pituitary hormone insufficiency associated with cleft lip and palate. Arch Dis Child 1978; 53: 952–955.
  6. Laron Z, Taube E, Kaplan I. Pituitary growth hormone insufficiency associated with cleft lip and palate. An embryonal developmental defect. Helv Paediatr Acta 1969; 24: 576–581.
  7. Azcona C, Stanhope R. Height and weight achievement in cleft lip and palate. Arch Dis Child 1997; 77: 187–188.
  8. Montagnoli LC, Barbieri MA, Bettiol H, Marques IL, de Souza L. Growth impairment of children with different types of lip and palate clefts in the first 2 years of life: a cross-sectional study. J Pediatr (Rio J) 2005; 81: 461–465.
  9. Marques IL, Nackashi JA, Borgo HC, Martinelli AP, PegoraroKrook MI, Williams WN, Dutka JC, Seagle MB, Souza TV, Garla LA et al. Longitudinal study of growth of children with unilateral cleft-lip palate from birth to two years of age. Cleft Palate Craniofac J 2009; 46: 603–609.
  10. McHeik JN, Levard G. Growth in infants in the first two years of life after neonatal repair for unilateral cleft lip and palate. Int J Pediatr Otorhinolaryngol 2010; 74: 465–468.
  11. Traggiai C, Stanhope R. Endocrinopathies associated with midline cerebral and cranial malformations. J Pediatr 2002; 140: 252–255.
  12. Rudman D, Davis T, Priest JH, Patterson JH, Kutner MH, Heymsfield SB, Bethel RA. Prevalence of growth hormone deficiency in children with cleft lip or palate. J Pediatr 1978; 93: 378–382. Lipman T,